CTIX Discussion Topics 08/19/2014 10:22:57 $CTIX The

New Post Public Reply Private Reply Replies (0) Message Board
Jake13
CTIX Discussion Topics 08/19/2014 10:22:57 $CTIX
The answer to your question is "no". Trial results are news that will sustain volume and price appreciation, not the (nearly 2 year) "anticipation" of results. And the prior poster was right in that we've seen this movie here before, many times. So far this one looks no different
$2.00 it is again....will she hold this time ?
Back to $2.00,... yes!!
there were PRs issued at the times of the SP fluctuations that explained them. SP doesn't follow charts imo, charts show up with SP movement after the fact.
recently dr menon said we would be getting lots of good news about CTIX compounds the last 2 weeks of august. that is happening now.

the company is registered for R&R conference sept 8-10. are you implying they intend to go there with either neutral or negative news?

i am expecting dcohort 8 news then which will be good.

i hope you can handle that.




Best consolidation and loading at this lever than any other previous attempt to crack $2.00.

If she breaks it this time and holds we could see $2.15-$2.30 very quickly....
BooDog, think day(s) not months . Major resistance from $2 to $2.40. More resistance the higher she goes until beyond this broad range. Again, ultimately the speed this will happen is very volume dependent. Sellers will increase supply, which must be absorbed for the price to advance.


"which provides benefits for both patients and society" Society is my favorite part. Sixty-six pounds of Brilacidin you don't manufacturer that much if it isn't working!
The CTIX link at ClinicalTrials.gov. Good reading, especially before bedtime. But, I know some are technical wonks:

http://clinicaltrials.gov/ct2/results?term=Ce...rch=Search
Is the finishing of two trials, and awaiting results actionable news?
Happy birthday WILD4CTIX! INH, sorry, that was a copy from my email from Cellceutix so didn't have a link. Plus I was on the way out the door for dental lol. Good call! Was thinking it would catch $2 but also it wants to get back inside the bollingers imo. A wee bit of volatility and then soon I think we'll start seeing a push towards pre marketing levels for B. Might be a month or so but I know I'm not going anywhere.

combined posts to save my #'s. lol

Cheers!
The action seems great the last few sessions but can't help but feel like I've been here before. Looking back at the chart, we have. Several times. Huge days seemingly out of the blue followed by consolidation all the way back to where we started or lower. Each time, the highs have gotten a bit lower. If this is the same type of action I expect we won't spend any significant time above $2 and this volume will be gone by the end of the week.

We saw more volume and similar action in may, july and September of last year and april of this year. When you look at those events our current volume is less than half.

It's exciting to watch but since this has come, yet again, without any actionable news I fully anticipate the pull back.
New article from Ellaruth. Apparently she, like most here, expects miracles from Kevetrin.

http://seekingalpha.com/instablog/21116141-el...n-oxymoron

georgejjl Saturday, 08/09/14 10:21:58 AM
Re: None
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Samuel Oschin Air & Space Center Takes Flight This Fall

Updated Category News Views 30

The Grand Unveiling: November Highlights Look at this: space nerds, dreamers, and just about anybody with a heartbeat and a sense of wonder should circle November 13, 2026, like a kid with a candy store gift card. That's when the California Science Center throws open the doors to the Samuel Oschin Air and Space Center. You might as well slap a 'world's first' sticker on...

Continue Reading
Software Updates Costly: UX Not the Biggest Culprit

Updated Category News Views 80

Breaking Updates Trump UX Changes Here's the real scoop: software updates that break functionality are setting companies back more than those user experience (UX) tweaks that folks gripe about but usually muddle through. According to a recent LITSLINK study, even three figures that supposedly quantify UX losses turn out to be questionable at best. Real-world Disasters:...

Continue Reading
Multiplier's Data Signals Global Hiring Evolution

Updated Category News Views 58

Shaking Up the Global Hiring Playbook You think you know how hiring works globally? Think again. Based on data from a whopping 38,000 cross-border hires, Multiplier's latest Talent Trends has spilled some hot new beans on how companies are rethinking their talent acquisition strategies. This isn’t just some thumb-twiddling speculation either—it’s grounded in real...

Continue Reading
York Space Systems Faces Turbulence Amid Investor Lawsuit

Updated Category News Views 46

York's Shaky Strategy Under the Microscope How do you go from sky-high ambitions to a grinding halt in a matter of weeks? This ain’t your typical Wall Street plot twist—it involves York Space Systems, or NYSE:YSS. These guys promised dominance in the Space Development Agency’s Transport Layer program, only to have their shooting star come crashing down. And now,...

Continue Reading
Tribal Tech Triumph: ILINX Boosts Proposal Efficiency

Updated Category News Views 72

A New Era for Tribal Operations Well, here's a headline that might've slipped under your radar, but it’s got some serious implications. Over in Olympia, Washington, ImageSource, Inc., the brains behind the ILINX platform, just scored a home run with an automated system for crafting Tribal Indirect Cost Rate Proposals (ICRPs). This ain't just gadget talk; this is a...

Continue Reading
2026 Data Integration Stars: User Sentiments Revealed

Updated Category News Views 18

Users Crown Data Integration Champions Right out of the gate, let's make one thing clear: when you're picking a data integration solution, you're essentially hitching your wagon to a vendor. This partnership, like any, can make or break your operations, and no one knows this better than the folks who've been through the trenches. Enter Infotech's 2026 Emotional Footprint...

Continue Reading
Greentown Labs Builds Momentum in Climate Innovation

Updated Category News Views 55

Paving the Way for Climate-Tech Pioneers Ah, Massachusetts—where the perfect storm of bright minds and groundbreaking innovation is brewing. It's not all just Harvard and MIT. It's programs like Greentown Labs' First Valley Fellowship stirring the pot, ushering in a new era of climate and energy startups. We're talking a robust second year for the Fellowship, where...

Continue Reading
CapCut Leads 2026 AI Image Tools for Creatives

Updated Category News Views 137

CapCut Emerges as a Go-To in AI Imagery There's no better feeling than striking gold in a flooded market. CapCut's got folks buzzing in 2026 for its top-tier AI image creation tools, according to Expert Consumers' latest rankings. On the surface, it might just seem like another tech gimmick, but dig a bit deeper, and you'll see why it's a game changer. From adland to...

Continue Reading
Step into Fear: Dead by Daylight in Moreno Valley

Updated Category News Views 8

Immersive Horror in Moreno Valley Walking straight into the fog of your nightmares isn't for the faint-hearted, but that's the kind of thrill the Moreno Valley Museum & ArtSpace is serving up with its new Dead by Daylight Immersive Experience. Kicking off just in time for Halloween on October 30, this isn't your average stroll in a museum—it's a heart-pounding,...

Continue Reading
Shareholder Lawsuit Targets Anavex Amid Falling Stock

Updated Category News Views 76

Anavex Under Fire: Investor Rights at the Forefront Another day, another lawsuit makin' waves in that fragile sea called the stock market. This time, it's Anavex Life Sciences Corp. (NASDAQ: AVXL) getting dunked in the soup for allegedly misleading their investors, leaving a bunch of folks wringing their hands and wallets. What's the Beef with Anavex? We've got a class...

Continue Reading

Top 5 Most Recently Viewed Articles

YY Inc's Profile Amidst Changing Streaming and Ad Markets

Updated Category News Views 237

YY Inc Adjusts Strategy Amidst Market Changes BofA Securities has recently reassessed the stock position of YY Inc (NASDAQ: YY), raising its price target to $36.00 from $35.00 while keeping a Neutral rating. This evaluation follows an in-depth look into the company's financial performance for the second half of the year, where growth prospects seem to showcase both...

Continue Reading
Collaboration Between Azenta and Form Bio to Transform Gene Therapy

Updated Category News Views 205

Strategic Partnership for AAV Gene Therapy Advancement In a significant push towards revolutionizing gene therapy, Azenta, Inc. (Nasdaq: AZTA) has partnered with Form Bio to enhance the development of adeno-associated virus (AAV) gene therapies. This collaboration aims to streamline the entire process of gene therapy development, ultimately providing safer and more...

Continue Reading
Dashlane Enhances Partner Program with New Incentives for Growth

Updated Category News Views 206

Dashlane Enhances Partner Program with New Incentives for Growth - New points-based program model equips and rewards resellers to expedite adoption of Dashlane Omnix™ - - Dashlane also appoints security industry veteran Tom Laffaye to lead its burgeoning channel business - Credential security leader Dashlane is excited to unveil significant enhancements to its Partner...

Continue Reading
Top Dividend Stocks Poised for Growth and Income Opportunities

Updated Category News Views 76

Introduction to High-Yield Dividend Stocks Investors are constantly seeking stocks that provide both a reliable income through dividends and significant growth potential. In today's economic environment, such opportunities are increasingly desirable. Identifying high-quality dividend-paying stocks can be the key for those looking to maximize returns. This article will...

Continue Reading
European Wax Center, Inc. Financial Report Update: Q2 2025 Insights

Updated Category News Views 113

Exciting Announcement from European Wax Center, Inc. European Wax Center, Inc. (EWCZ) is a frontrunner in the waxing services industry across the United States. The company is gearing up to share its financial performance for the second quarter of fiscal year 2025. This eagerly awaited announcement will occur on a Wednesday morning, prior to the market opening. The...

Continue Reading